US Pharm. 2013;38(11):6.
Columbia, MO—A study conducted at the University of Missouri (MU) found that resveratrol, a compound in grapes and red wine, can render certain tumor cells more susceptible to radiation. The study, which examined how resveratrol and radiation inhibited the survival of melanoma cells, was preceded by an MU study of the compound that found similar results for prostate cancer. Melanoma cells were more susceptible to radiation after resveratrol treatment. Sixty-five percent of melanoma cells treated with resveratrol plus radiation died, versus 44% of melanoma cells treated with resveratrol alone. The next step is to develop a successful method for delivering the compound to tumor sites and potentially treat many types of cancer.
To comment on this article, contact firstname.lastname@example.org.